Advertisement

Molecular and Cellular Biochemistry

, Volume 261, Issue 1, pp 57–61 | Cite as

Orally administered tryptophan and experimental type 2 diabetes

  • M.A. Tormo
  • A. Romero de Tejada
  • I. Morales
  • S. Paredes
  • S. Sánchez
  • C. Barriga
  • R. Hernández
Article

Abstract

There is a link between diabetes and oxidative stress. Hyperglycaemia leads to free radical generation and alterations of endogenous antioxidants. Our aim is to study the effect of orally administered L-tryptophan (TRP), the melatonin precursor, an endogenous antioxidant, on circulating levels of glycaemia, insulin and melatonin, and on the superoxide dismutase and catalase antioxidant systems in non-diabetic (ND) and type 2 diabetic (n5-STZ) male Wistar rats.

At 19:30 every day for 15 days, TRP (125 mg/kg body weight) was administered orally. At 09:00 every two days the glycaemia was measured and every day the intake of food and water was recorded. At the beginning and end of treatment (at 09:00; 21:00; 02:00) plasma insulin and melatonin levels were measured, and (at 09:00) the enzymatic activities of catalase and superoxide dismutase (SOD) in erythrocytes were also measured. Glycaemia values were greater (p < 0.01) in n5-STZ rats than in ND rats, while insulin levels were lower (p < 0.05) at all times studied and these parameters were not altered by the TRP administration. Melatonin levels at 02:00 were lower in n5-STZ than in ND rats (p < 0.05). The TRP administration did not modify the circulating melatonin levels in ND rats, but raised (p < 0.01) the levels at 02:00 in the treated n5-STZ group. In ND rats after TRP administration there was a decline in catalase activity (p < 0.05), while in n5-STZ rats there was a rise (p < 0.01) at the end of treatment. However, there were no significant changes in SOD activity. There was increased food intake (g/day) in the treated n5-STZ group (p < 0.01). In conclusion, the oral administration of TRP did not modify glycaemia or insulinaemia levels, but raised melatonin levels in diabetic rats at 02:00, lowered catalase activity in ND rats but raised it in n5-STZ rats, and increased food intake in n5-STZ rats. (Mol Cell Biochem 261: 57–61, 2004)

catalase food intake glycaemia insulin L-tryptophan melatonin superoxide dismutase type 2 diabetes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cross CE, Hallivell B, Borish ET: Oxygen radicals and human disease. Ann Intern Med 107: 526–545, 1987PubMedGoogle Scholar
  2. 2.
    Ceriello A: The possible role of postprandial hyperglycaemia in the pathogenesis of diabetics complications. Diabetologia 46: M9–M116, 2003PubMedGoogle Scholar
  3. 3.
    Paolisso G, Giugliano D: Oxidative stress and insulin action: Is there a relationship? Diabetologia: 357–363, 1996Google Scholar
  4. 4.
    Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hiperglycemic damage. Nature 404: 787–790, 2000PubMedGoogle Scholar
  5. 5.
    Halliwell B, Gutteridge JM: Free radicals in biology and medicine. Arch Biochem Biophys 246: 501–514, 1986CrossRefPubMedGoogle Scholar
  6. 6.
    Hiramatsu K, Arimori S: Increased superoxide production by mononuclear cells of patients with hypertryglycerdemia and diabetes. Diabetes 37: 832–837, 1988PubMedGoogle Scholar
  7. 7.
    Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405–412, 1988Google Scholar
  8. 8.
    Segrouchni I, Drai J, Bannier E, Riviere J, Calmard P, García I, Orgiazzi J, Revol A: Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus: Insulin treatment efficiency. Clin Chim Acta 321: 89–96, 2002Google Scholar
  9. 9.
    Tankova T, Koev D, Dakovska L, Kirilov, G: The effect of replaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 59: 43–49, 2003CrossRefPubMedGoogle Scholar
  10. 10.
    Reiter RJ: Melatonin: Lowering the high price of free radicals. News Physiol Sci 15: 246–250, 2000PubMedGoogle Scholar
  11. 11.
    Montilla PL, Vargas JF, Tunez IF, Munoz de Agueda MC, Valdelvira ME, Cabrera ES: Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin. J Pineal Res 25: 94–100, 1998PubMedGoogle Scholar
  12. 12.
    Sailaja Devi MM, Suresh Y, Das UN: Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 29: 108–115, 2000CrossRefPubMedGoogle Scholar
  13. 13.
    Nishida S, Segawa T, Murai I, Nakagawa S: Long term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of delta-5-desaturase activity. J Pineal Res 32: 26–33, 2002CrossRefPubMedGoogle Scholar
  14. 14.
    Herrera R, Manjarrez G, Nishimura E, Hernandez J: Serotonin-related tryptophan in children with insulin dependent diabetes. Pediatr Neurol 28: 20–23, 2003CrossRefPubMedGoogle Scholar
  15. 15.
    Manjarrez Gutierrez G, Herrera Marquez JR, Molina Hernandez A, Hernandez J: Alteraciones de la neurotransmision serotoninergica cerebral inducida por diabetes mellitus tipo 1. Rev Invest Clin 51: 293–302, 1999PubMedGoogle Scholar
  16. 16.
    Huether G, Poeggeler B, Reimer A, George A: Effect of tryptophan administration on circulating melatonin levels in chicks and rats: Evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 51: 945–953, 1992CrossRefPubMedGoogle Scholar
  17. 17.
    Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi-Fanelli F: Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord 22: 648–654, 1998CrossRefPubMedGoogle Scholar
  18. 18.
    Portha B, Blondel O, Serradas P, McEvoy R, Giroix MH, Kergoat M, Bailbe D: The rat models of non-insulin-dependent diabetes induced by neonatal streptozotocin. Diabetes Metab, 15: 61–75, 1989Google Scholar
  19. 19.
    Aebi H: Catalase in vitro. Methods Enzymol 105: 121–126, 1984PubMedGoogle Scholar
  20. 20.
    Ceriello A: Acute hyperglycaemia and oxidative stress generation. Diabet Med 14(suppl 3): S45–S49, 1997PubMedGoogle Scholar
  21. 21.
    Klein DC, Weller JL: Indole metabolism in the pineal gland: A circadian rhythm in N-acetyltransferase. Science 169: 1093–1095, 1970PubMedGoogle Scholar
  22. 22.
    Manjarrez GG, Herrera MJR, Bueno SS, Gonzalez RM, Hernandez RJ: Cambios en la biosintesis de serotonina cerebral en ratas con diabetes mellitus inducida por estreptozotocina. Efecto del tratamiento con insulina. Rev Invest Clin 52: 509–516, 2000Google Scholar
  23. 23.
    Champney TH, Holtorf AP, Craft CM, Reiter RJ: Hormonal modulation of pineal melatonin synthesis in rats and Syrian hamsters: Effects of streptozotocin-induced diabetes and insulin injections. Comp Biochem Physiol 83: 319–395, 1986CrossRefGoogle Scholar
  24. 24.
    Champney TH, Brainard GC, Richardson BA, Reiter RJ: Experimentally-induced diabetes reduces nocturnal pineal melatonin content in the Syrian hamster. Comp Biochem Physiol, 76: 199–201, 1983CrossRefGoogle Scholar
  25. 25.
    Kesavulu MM, Giri R, Kameswara Rao B, Apparao C: Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab, 26: 387–392, 2000PubMedGoogle Scholar
  26. 26.
    Torres MD, Canal JR, Perez C: Oxidative stress in normal and diabetic rats. Physiol Res 48: 203–208, 1999PubMedGoogle Scholar
  27. 27.
    Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK: Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 15: 165–173, 2002Google Scholar
  28. 28.
    Dominguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 10: 1736–1742, 1998Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • M.A. Tormo
    • 1
  • A. Romero de Tejada
    • 1
  • I. Morales
    • 1
  • S. Paredes
    • 1
  • S. Sánchez
    • 1
  • C. Barriga
    • 1
  • R. Hernández
    • 1
  1. 1.Departamento Fisiología, Facultad de MedicinaUniversidad de ExtremaduraBadajozSpain

Personalised recommendations